MORPHOLINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF Russian patent published in 2003 - IPC

Abstract RU 2201924 C2

FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes morpholine derivative of the formula (I) or its pharmaceutically acceptable salt where R1 is taken among group including: (1) hydrogen atom; (2) C1-6-alkyl that is unsubtituted or substituted with phenyl or heterocycle where heterocycle is taken among group including imidazolyl or triazolyl and where heterocycle is unsubstituted or substituted with oxo-group; each of R2 and R3 means hydrogen atom; R6, R7, R8 are taken independently among group including: (1) hydrogen atom; (2) hydrogen atom, C1-6-alkyl substituted with halogen atom and (3) halogen atom; R11, R12, R13 are taken independently among hydrogen and halogen atom; X means -O-; Y means -O-; Z represents -alkyl. Novel compounds are antagonists of tachykinin receptors. Invention describes also pharmaceutical composition comprising effective dose of compound by claim 1. EFFECT: valuable medicinal properties of compound. 14 cl

Similar patents RU2201924C2

Title Year Author Number
SUBSTITUTED MORPHOLINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF COUNTERACTION TO SUBSTANCE P OR INHIBITION OF NEUROKININ-1 RECEPTORS 1995
  • Konrad P. Dorn
  • Dzheffri Dzh. Khejl
  • Mal'Kol'M Makkoss
  • Sander G. Mills
RU2170233C2
SUBSTITUTED HETEROCYCLES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALT, PHARMACEUTICAL COMPOSITION FOR BLOCKADE OF NEUROKININ-1 RECEPTORS IN MAMMALS, METHOD OF BLOCKADE OF NEUROKININ-1 RECEPTORS IN MAMMALS 1993
  • Konrad P.Dorn
  • Dzheffri Dzh.Khejl
  • Mal'Kol'M Mehkkoss
  • Sander Dzh.Millz
  • Tamara Lehdduvakhetti
  • Shrenik K.Shakh
RU2140914C1
SUBSTITUTED MORPHOLINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON SAID, METHOD OF DECREASE OF TACHIKININ LEVEL IN TREATMENT OR PROPHYLAXIS OF PHYSIOLOGICAL STATES ASSOCIATED WITH TACHIKININ EXCESS 1994
  • Rejmond Bejker
  • Timoti Kharrison
  • Angus Mjurrej Makled
  • Ehndrju Pehjt Ouvens
  • Ehjlin Mehri S'Juard
  • Kristofer Dzhon Svejn
  • Martin Richard Till
RU2131426C1
PROCESS OF OBTAINING 5-[[2 (R)-[1 (R)-[3,5-BIS(TRIFLUOROMETHYL) PHENYL]ETHOXY]-3(8)-(4-FLUOROPHENYL)-4-MORPHOLINYL]METHYL]-1,2-DIHYDRO-3H-1,2,4-TRIAZOLE-3-ONE 2003
  • Khaffman Mark
  • Kaba Makhmud S.
  • Pehjak Dzhozef F.
  • Khehndz Dehvid
RU2326879C2
COMBINATION OF HIV-PROTEASE INHIBITOR WITH OTHER ANTIVIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON SAID AND METHOD OF PHARMACEUTICAL COMPOSITION PREPARING 1994
  • Dzhozef P.Vakka
  • Dzhejms P.Gar
  • Brjus D.Dorsi
  • M.Katarin Khollouehj
  • Rehndall V.Khangejt
RU2139052C1
DERIVATIVES OF 1,2,4-TRIAZOLE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 2003
  • Olson Stiven Kh.
  • Balkovets Dzhejms M.
  • Zkhu Juping
RU2319703C2
TRIAZOLE DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROIDDEHYDROGENASE-1 2003
  • Uoddell Sherman T.
  • Santorelli Dzhina M.
  • Maletik Milana M.
  • Leeman Aaron G.
  • Gu Sin'
  • Grehkhem Donal'D U.
  • Balkovets Dzhejms M.
  • Aster S'Juzan D.
RU2360910C2
DERIVATIVES OF PIPERAZINYLPENTAMIDE AND PHARMACEUTICAL COMPOSITION FOR INHIBITION OF HIV-PROTEASE ACTIVITY 1992
  • Dzhozef P.Vakka
  • Brjus D.Dorsi
  • Dzhejms P.Guar
  • Katrin M.Khollovej
  • Rehndell V.Khangejt
RU2131416C1
TYPE 1 DIACYLGLYCEROL-O-ACYLTRANSFERASE ENZYME INHIBITORS 2008
  • Lju Gan
  • Sin' Chzhili
  • Kim Filip R.
  • Sauehrs Ehndrju Dzh.
RU2486186C2
AKT ACTIVITY INHIBITORS 2006
  • Armstrong Donna Dzh.
  • Khu Ehssa Kh.
  • Kelli Majkl Dzh. Iii
  • Lejton Mark Eh.
  • Li Ivehj
  • Ljan Tszjun'
  • Rodzinak Kevin Dzh.
  • Rossi Majkl A.
  • Sanderson Filip Eh.
  • Van Tszjabin
RU2421454C2

RU 2 201 924 C2

Authors

Dorn Konrad P.

Fink Pol E.

Khejl Dzheffri Dzh.

Makkos Malkolm

Mills Sender Dzh.

Shakh Shrenik K.

Chemberz Mark Stjuart

Garrison Timoti

Laddvagetti Tamara

Villiams Brajan Dzhon

Dates

2003-04-10Published

1994-12-13Filed